| The association between co-morbidity and the use of antidiabetics or adjunctive cardiovascular medicines in Australian veterans with diabetes. | |
| | |
MedLine Citation:
|
PMID: 21067836 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
OBJECTIVE: to examine the association between co-morbidities and the use of antidiabetic medications or adjunctive cardiovascular medicines among Australian veterans with diabetes. METHODS: data were sourced from the Australian Department of Veterans' Affairs Health Claims database. All veterans aged 65 years and over who were dispensed medicines for diabetes from July to December 2006 were included. Dispensings of antidiabetic and adjunctive cardiovascular medicines over the first six months of 2007 were examined. Log binominal regression models were used to calculate the relative risks of the dispensing of medications for various co-morbidities, taking into account potential confounders. RESULTS: among the 14,802 veterans who were dispensed medicines for diabetes, 70% had five or more co-morbidities. Patients who had diabetes-related co-morbidities had significantly less dispensing of metformin monotherapy and more dispensing of insulin than those without these conditions. Patients who had cardiovascular disease were more likely to have three or more oral antidiabetics dispensed (RR=1.16, 95% CI: 1.04-1.30), particularly those who had heart failure (RR=1.24, 95% CI: 1.05-1.47). Patients with renal disease were more likely to have glitazones dispensed (RR=1.46, 95% CI: 1.24-1.72). Adjunctive cardiovascular medicines were significantly less likely to be dispensed to those with established heart conditions and non-related co-morbidities, particularly dementia. CONCLUSIONS: consistent with guideline recommendations, in this cohort more intensive antidiabetic and cardiovascular therapy is used in those with more severe disease as measured by related co-morbidities. Cardiovascular medicines however may be underutilised in those with un-related co-morbidities. |
| | |
Authors:
|
Ying Zhang; Agnes Vitry; Gillian Caughey; Elizabeth E Roughead; Philip Ryan; Andrew Gilbert; Sepehr Shakib; Robyn McDermott |
Related Documents
:
|
19765176 - Regenerative medicine: a 2009 overview. 17370976 - Ensuring prudent use of antimicrobials in human medicine in the european union, 2005. 3560256 - A sense of tragedy: medicine, the profession. 22606746 - Herophilus of chalcedon and the hippocratic tradition in early alexandrian medicine. 7675746 - Genital ulcer disease. management in the hiv era. 20060256 - Who's in charge? the role of responsibility attribution in self-management among people... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2010-11-09 |
Journal Detail:
|
Title: Diabetes research and clinical practice Volume: 91 ISSN: 1872-8227 ISO Abbreviation: Diabetes Res. Clin. Pract. Publication Date: 2011 Jan |
Date Detail:
|
Created Date: 2010-12-28 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8508335 Medline TA: Diabetes Res Clin Pract Country: Ireland |
Other Details:
|
Languages: eng Pagination: 115-20 Citation Subset: IM |
Copyright Information:
|
2010 Elsevier Ireland Ltd. All rights reserved. |
Affiliation:
|
Faculty of Health Sciences, University of Adelaide, Adelaide, South Australia 5005, Australia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Type 2 diabetes does not attenuate racial differences in coronary calcification.
Next Document: Contribution of glimepiride to basal-prandial insulin therapy in patients with type 2 diabetes.